Impact of physicochemical properties of engineered fullerenes on key biological responses

Toxicology and Applied Pharmacology

Volumn 234, Issue 1, 2009, Pages 58-67

  Rebecca, Martin ^a   Hsing Lin, Wang ^a   Jun, Gao ^a   Srinivas, Iyer ^a   Gabriel, Montaño A ^a   Jennifer, Martinez ^a   Andrew, Shreve P ^a   Yuping, Bao ^a   Chun Chih, Wang ^a   Zhong, Chang ^a   Yuan, Gao ^b   Rashi, Iyer ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b Sensor Research and Development Corporation   (United States)

Author keywords

Apoptosis; Carboxyfullerene; Caspases; Cell signaling; Free radical; Nanoparticle

Indexed keywords

CASPASE; FULLERENE DERIVATIVE; REACTIVE OXYGEN METABOLITE; VALINOMYCIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL CULTURE; CELL DEATH; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; CYTOTOXICITY; DERIVATIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROPHILICITY; LIGHT SCATTERING; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; SIGNAL TRANSDUCTION; SOLUBILITY; SYNTHESIS; WESTERN BLOTTING;

ANTIOXIDANTS; APOPTOSIS; CARBOXYLIC ACIDS; CELL LINE; ELECTROCHEMISTRY; FULLERENES; HUMANS; MONOCYTES; NECROSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SOLUBILITY; SURFACE PROPERTIES;

EID: 57249097035     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.08.021     Document Type: Article

References (41)

1. Abdalah R., Wei L., Francis K., and Yu S.P. Valinomycin-induced apoptosis in Chinese hamster ovary cells. Neurosci. Lett. 405 (2006) 68-73
2. Adams P.D., Grosse-Kunstleve R.W., Hung L.-W., Ioerger T.R., McCoy A.J., Moriarty N.W., Read R.J., Sacchettini J.C., Sauter N.K., Terwilliger T.C., Kroto H.W., Heath J.R., Obrien S.C., Curl R.F., and Smalley R.E. C60: buckminsterfullerene. Nature 318 (1985) 162-163
3. Bisaglia M., Natalini B., Pellicciari R., Straface E., Malorni W., Monti D., Franceschi C., and Schettini G. C3-fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis. J. Neurochem. 74 (2000) 1197-1204
4. Bolskar R.D., Benedetto A.F., Husebo L.O., Price R.E., Jackson E.F., Wallace S., Wilson L.J., and Alford J.M. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J. Am. Chem. Soc. 125 (2003) 5471-5478
5. Borm P.J., and Kreyling W. Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J. Nanosci. Nanotechnol. 4 (2004) 521-531
6. Bosi S., Da Ros T., Spalluto G., Balzarini J., and Prato M. Synthesis and anti-HIV properties of new water-soluble bis-functionalized[60]fullerene derivatives. Bioorg. Med. Chem. Lett. 13 (2003) 4437-4440
7. Bosi S., Da Ros T., Spalluto G., and Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur. J. Med. Chem. 38 (2003) 913-923
8. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., Bruinink A., and Stark W.J. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 40 (2006) 4374-4381
9. Camps X., and Hirsch A. Efficient cyclopropanation of C60 starting from malonates. Perkin Trans. 11 (1997) 1595-1596
10. Chang H.Y., and Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol. Mol. Biol. Rev. 64 (2000) 821-846
11. Chellat F., Merhi Y., Moreau A., and Yahia L.H. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 26 (2005) 7260-7275
12. Dugan L.L., Gabrielsen J.K., Yu S.P., Lin T.S., and Choi D.W. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 3 (1996) 129-135
13. Dugan L.L., Lovett E.G., Quick K.L., Lotharius J., Lin T.T., and O'Malley K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 7 (2001) 243-246
14. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68 (1999) 383-424
15. Foley S., and al e. Interaction of a water soluble fullerene derivative with reactive oxygen species and model enzymatic systems. Fuller. Nanotub. Carbon Nanostruct. 10 (2002) 49-67
16. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B.F., Seta P., and Larroque C. Cellular localisation of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun. 294 (2002) 116-119
17. Friedman S.H., Decamp D.L., Sijbesma R.P., Srdanov G., Wudl F., and Kenyon G.L. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc. 115 (1993) 6506-6509
18. Gaspar R., Preat V., Opperdoes F.R., and Roland M. Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm. Res. 9 (1992) 782-787
19. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
20. Hoet P.H., Bruske-Hohlfeld I., and Salata O.V. Nanoparticles - known and unknown health risks. J. Nanobiotechnology 2 (2004) 12
21. Isakovic A., Markovic Z., Todorovic-Markovic B., Nikolic N., Vranjes-Djuric S., Mirkovic M., Dramicanin M., Harhaji L., Raicevic N., Nikolic Z., and Trajkovic V. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol. Sci. 91 (2006) 173-183
22. Isobe H., Mashima H., Yorimitsu H., and Nakamura E. Synthesis of fullerene glycoconjugates through sulfide connection in aqueous media. Org. Lett. 5 (2003) 4461-4463
23. Kam P.C., and Ferch N.I. Apoptosis: mechanisms and clinical implications. Anaesthesia 55 (2000) 1081-1093
24. Kaufmann S.H., and Gores G.J. Apoptosis in cancer: cause and cure. Bioessays 22 (2000) 1007-1017
25. Labhasetwar V., Song C., Humphrey W., Shebuski R., and Levy R. Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J. Pharm. Sci. 87 (1998) 1229-1234
26. Lamparth I., and Hirsch A. Water soluble malonic acid derivatives of C60 with a defined three-dimesional structure. J. Chem. Soc. Chem. Commun. (1994) 1727-1728
27. Lin A.M., Chyi B.Y., Wang S.D., Yu H.H., Kanakamma P.P., Luh T.Y., Chou C.K., and Ho L.T. Carboxyfullerene prevents iron-induced oxidative stress in rat brain. J. Neurochem. 72 (1999) 1634-1640
28. Monti D., Moretti L., Salvioli S., Straface E., Malorni W., Pellicciari R., Schettini G., Bisaglia M., Pincelli C., Fumelli C., Bonafe M., and Franceschi C. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 277 (2000) 711-717
29. Nakamura E., and Isobe H. Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. Acc. Chem. Res. 36 (2003) 807-815
30. Nose K. Role of reactive oxygen species in the regulation of physiological functions. Biol. Pharm. Bull. 23 (2000) 897-903
31. Priyadarsini K., Mohan H., Tyagi A., and Mittal J. Inclusion complex of gcyclodextrin-C60: formation, characterization and photophysical properties in aqueous dolution. L. Phys. Chem. 98 (1994) 4756-4759
32. Sayes C., Fortner J., Guo W., Lyon D., Boyd A., Ausman K., Tao Y., Sitharaman B., Wilson L., Hughes J., West J., and Colvin V. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 4 (2004) 1881-1887
33. Sayes C.M., Gobin A.M., Ausman K.D., Mendez J., West J.L., and Colvin V.L. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 26 (2005) 7587-7595
34. Schinazi R.F., Sijbesma R., Srdanov G., Hill C.L., and Wudl F. Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene. Antimicrob. Agents Chemother. 37 (1993) 1707-1710
35. Sijbesma R., Srdanov G., Wudl F., Castoro J.A., Wilkins C., Friedman S.H., Decamp D.L., and Kenyon G.L. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J. Am. Chem. Soc. 115 (1993) 6510-6512
36. Sitharaman B. Nanoscale aggregation properties of neuroprotective carboxyfullerene (C3) in aqueous solution. Nano Lett. 4 (2004) 1759-1762
37. Tsao N., Luh T.Y., Chou C.K., Chang T.Y., Wu J.J., Liu C.C., and Lei H.Y. In vitro action of carboxyfullerene. J. Antimicrob. Chemother. 49 (2002) 641-649
38. Weissleder R., Kelly K., Sun E.Y., Shtatland T., and Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol. 23 (2005) 1418-1423
39. Xia S.L., Rosen E.M., Laterra J., Keramaris E., Stefanis L., MacLaurin J., Harada N., Takaku K., Ishikawa T., Taketo M., Robertson G., Nicholson D., Slack R., and Park D. Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage. Mol. Cell. Neurosci. 15 (2000) 368-379
40. Xia S.L., Rosen E.M., and Laterra J. Sensitization of glioma cells to fas-dependent apoptosis by chemotherapy-induced oxidative stress. Cancer Res. 65 (2005) 5248-5255
41. Yih T.C., and Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 97 (2006) 1184-1190